Our innovative R&D studies are carried out by taking the developments in molecular biology and biotechnology into account. Besides, studies are carried out for the licensing of products, especially in the FDA, in Europe and other countries.
One of our key priorities is to ensure that our products which were produced by domestic resources and high technology are introduced to international markets. Another important goal is to offer different molecules developed to the usage of patients with innovative medical devices that provide ease of application.
ARVEN Pharmaceutical Industry founded in the last month of 2013 within the Toksöz Group, is continuing its activities in the fields of respiratory and biotechnology treatment.
ARVEN Pharmaceuticals aims to be an institution that operates with a sense of respect for the environment and contributes to the maintenance of human health while inheriting quality as a lifestyle.
Toksöz Group Human Resources implements a meticulous recruitment process to create a pleasant working environment
